Showing results (71-80 of 202) with videos related to

Sort By:
Pageof 21
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 7, 2023
Prevalence of unmet supportive care needs reported by individuals ever diagnosed with cancer in Australia: a systematic review to support service prioritisationJackie Roseleur, Laura Catherine Edney, Jayda Jung, et al.
BMJ Open Quality|November 4, 2024
Achieving and sustaining reduction in hospital-acquired complications in an Australian local health serviceQun Catherine Li, Jim Codde, Jonathan Karnon, et al.
Australian Health Review : a Publication of the Australian Hospital Association|September 1, 2012
A model-based evaluation of collaborative care in management of patients with type 2 diabetes in Australia: an initial reportHossein Haji Ali Afzali, Jonathan Karnon, Jodi Gray, et al.
Plos One|August 24, 2023
Development and validation of an individual-based state-transition model for the prediction of frailty and frailty-related eventsAubyn Pincombe, Hossein Haji Ali Afzali, Renuka Visvanathan, et al.
Australian Health Review : a Publication of the Australian Hospital Association|September 29, 2025
Is a wholistic quality improvement program to reduce hospital-acquired complications economically viable in an Australian local health service?Qun Catherine Li, Jonathan Karnon, Dana A Hince, et al.
Infection, Disease & Health|January 9, 2020
Estimating the utilisation of unregistered antimicrobials in AustraliaNadine T Hillock, Jonathan Karnon, John Turnidge, et al.
Plos One|March 24, 2022
Effect of a multi-faceted rapid response system re-design on repeat calling of the rapid response teamRichard Chalwin, Amy Salter, Jonathan Karnon, et al.
BMC Medical Education|July 14, 2011
Is different better?: models of teaching and their influence on the net financial outcome for general practice teaching postsCaroline O Laurence, Linda E Black, Carolyn Cheah, et al.
Cost Effectiveness and Resource Allocation : C/E|October 21, 2016
What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in AustraliaJonathan Karnon, Ainul Shakirah Shafie, Nneka Orji, et al.
Pageof 21